OCX

ONCOCYTE
AMEX

实时行情|Nasdaq Last Sale

2.440
+0.050
+2.09%
休市 16:00 04/09 EDT
开盘
2.440
昨收
2.390
最高
2.470
最低
2.375
成交量
12.87万
成交额
--
52周最高
5.60
52周最低
1.500
市值
1.52亿
市盈率(TTM)
-5.6377
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测OCX价格均价为6.23,最高价位7.75,最低价为5.00。

EPS

OCX 新闻

更多
  • 白俄罗斯总理建议欧亚经济联盟大力推动去美元化进程
  • 央视 · 2小时前
  • 摩根大通大幅下调对美国经济前景的预期
  • 新浪财经综合 · 2小时前
  • 2.3万亿美元并非最后一搏,美联储还能继续放水!
  • 新浪财经综合 · 2小时前
  • 美股战“疫”小记:美股在这个早春都经历了什么?
  • 新浪财经综合 · 2小时前

所属板块

生物技术和医学研究
+1.63%
制药与医学研究
+0.82%

热门股票

代码
价格
涨跌幅

OCX 简况

OncoCyte Corporation is a development-stage biotechnology company focused in the field of regenerative medicine. The Company is developing molecular cancer diagnostics utilizing a discovery platform that focuses on identifying genetic markers expressed in various types of cancer. It operates through the research and development of diagnostic tests for the detection of cancer segment. Its initial focus will be confirmatory diagnostics, utilizing liquid biopsy technology, for use in conjunction with imaging to confirm initial diagnoses within certain oncology indications. In addition, it will be developing screening diagnostics as replacements for screening imaging procedures. For some indications, it will also be pursuing the probability of recurrence of a specific cancer through the development of prognostics or companion diagnostics that help a physician determine which therapy is the optimal treatment for the patient. It offers diagnostic tests for lung, breast and bladder cancer.
展开

微牛提供OncoCyte Corp(AMEX-OCX)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的OCX股票新闻,以帮助您做出投资决策。